Background and aim: Viral hepatitis and human immunodeficiency virus (HIV) infection are important causes of morbidity and mortality in hemodialysis (HD) patients. The present study was performed to assess the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and HIV infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. Methods: All patients undergoing maintenance HD at our center were screened for hepatitis B surface antigen (HBsAg), antibody to HCV (anti-HCV), antibody to HDV (anti-HDV) and HIV antibody by ELISA. Detailed history regarding age, sex, duration of dialysis, blood transfusions, number of dialysis centers, dialyzer reuse and laboratory data was recorded. Results: A total of 118 patients (79 males and 39 females) were followed for 18 months with screening for the presence of HBV, HCV and HIV infections. At baseline, 12 (10.2%) patients were positive for HBsAg, 19 (16.1%) for anti-HCV and 2 (1.7%) for HIV antibody. Over 18 months, one additional patient became HBsAg positive and an additional 17 became anti-HCV-positive to give a total of 36 HCV-positive patients. Dual HBV and HCV infection was seen in 5 (4.2%) and anti-HDV antibodies were found in 1 (0.9%) patient. History of blood transfusions, duration of HD, dialyzer reuse and dialysis at multiple centers were found to be important risk factors for anti-HCV positivity. 1,2 The prevalence of these infections is known to vary widely in different regions of the world. Even within India, a very wide range of prevalence rates for HBV (3.4-45%) and in the dialysis population have been reported.3 These prevalence rates are higher than the average prevalence rates estimated for the general population in India (4.7% and 1.85% for HBV and HCV respectively).
4,5HBV infection is less prevalent than HCV in HD units.
6Introduction of HBV vaccination, isolation of HBV positive patients, use of dedicated dialysis machines and regular surveillance for HBV infection have dramatically reduced the spread of HBV in this setting. 7 The prevalence of HCV infection among HD is high and varies between countries and between dialysis units within a single country.8 Dual infection with HBV and HCV leads to more aggressive liver disease in patients with ESRD on HD.